MDCO

Biotech Stock Roundup: Amgen Starts Earnings Season on Strong …

Earnings season in the biotech sector started on a positive note with Amgen (AMGN – Analyst Report) reporting better-than-expected first quarter 2015 results. Meanwhile, The Medicines Co. (MDCO – Analyst Report) received some good news with an FDA advisory panel backing its antiplatelet agent. However, companies like Athersys (ATHX – Snapshot Report) and Ampio suffered setbacks on the pipeline front.Recap […]

The Medicines Company to Host Surgery and Perioperative Care Investor and Analyst Meeting on May 22

[Business Wire] – The Medicines Company has scheduled a surgery and perioperative care investor and analyst meeting for Thursday, May 22, 2014 from 8:30 am to 12:00 noon. The event will be held at the Company’s Global Center 1 at 8 Sylvan Way in Parsippa moreView todays social media effects on MDCOView the latest stocks trending across Twitter. Click to […]

The Medicines Company to Participate in 2014 Bank of America Global Healthcare Conference

[Business Wire] – The Medicines Company is scheduled to present at the 2014 Bank of America Healthcare Conference in Las Vegas, NV on May 13th at 9:20 AM Pacific Time / 12:20 PM Easte moreView todays social media effects on MDCOView the latest stocks trending across Twitter. Click to view dashboardSee who The is hiring next, click here to view […]

The Medicines Company Receives Complete Response Letter From FDA Requesting Additional Information for New Drug Application for Its Antiplatelet Agent Cangrelor

[Marketwired] – The Medicines Company today announced that the U.S. Food and Drug Administration has issued a Complete Response Letter for the Company’s new drug application for its investigational intravenous antiplatelet … moreView todays social media effects on MDCOView the latest stocks trending across Twitter. Click to view dashboardSee who The is hiring next, click here to view […]

THE MEDICINES COMPANY 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Securities Class Action Lawsuit Against the Medicines Company – MDCO

[GlobeNewswire] – NEW ORLEANS — Kahn Swick & Foti, LLC (KSF) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with large financial interests that they have only … moreView todays social media effects on MDCOView the latest stocks trending across Twitter. Click to view dashboardSee who The is hiring next, click here to […]

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against The Medicines Company and Certain Officers – MDCO

[Marketwired] – Pomerantz LLP has filed a class action lawsuit against The Medicines Company and certain of its officers. The class action, filed in United States District Court, District of New Jersey, and docketed under … moreView todays social media effects on MDCOView the latest stocks trending across Twitter. Click to view dashboardSee who The is hiring next, click here […]